Commission Regulation (EC) No 1282/2002 of 15 July 2002 amending Annexes to Council Directive 92/65/EEC laying down animal health requirements governing trade in and imports into the Community of animals, semen, ova and embryos not subject to animal health requirements laid down in specific Community rules referred to in Annex A(1) to Directive 90/425/EEC (Text with EEA relevance)
Date: 2002-07-15
Institutions: European Commission
Subjects: animal disease, health certificate, live animal, trading operation, veterinary inspection

16.7.2002

EN

Official Journal of the European Communities

L 187/3

COMMISSION REGULATION (EC) No 1282/2002

of 15 July 2002

amending Annexes to Council Directive 92/65/EEC laying down animal health requirements
governing trade in and imports into the Community of animals, semen, ova and embryos not
subject to animal health requirements laid down in specific Community rules referred to in Annex
A(1) to Directive 90/425/EEC

(Text with EEA relevance)

THE COMMISSION OF THE EUROPEAN COMMUNITIES,

Having regard to the Treaty establishing the European
Community,

Having regard to Council Directive 92/65/EEC of 13 July 1992
laying down animal health requirements governing trade in and
imports into the Community of animals, semen, ova and
embryos not subject to animal health requirements laid down
in specific Community rules referred to in Annex A(1) to Direc-
tive 90/425/EEC (1), as last amended by Commission Decision
2001/298/EC (2), and in particular Article 22 thereof.

Whereas:

(1)

(2)

According to the experience of the Member States with
the implementation of Directive 92/65/EEC in relation to
the trade in the animals referred to in Articles 5, 13 and
23 of that Directive, there is a need to clarify the require-
ments for approved bodies, institutes or centres and to
include certain quarantine provisions.

Therefore, it is necessary to make some technical adapta-
tions concerning the conditions governing the approval
of bodies, institutes or centres, to introduce a specific
certificate for trade in these animals and to clarify the list
of notifiable diseases.

(3)

Those bodies, institutions or centres already approved by
should
Member States under

the old arrangements

(4)

(5)

(6)

continue to be approved and brought into line with the
new requirements as soon as possible.

Annexes A, C and E to Directive 92/65/EEC should
therefore be amended accordingly.

In order to ensure that there is an appropriate period of
time for these provisions to be implemented in all
Member States, a date for the implementation of this
Regulation should be laid down.

The measures provided for in this Regulation are in
accordance with the opinion of the Standing Committee
on the Food Chain and Animal Health,

HAS ADOPTED THIS REGULATION:

Article 1

Annexes A, C and E to Directive 92/65/EEC are amended as set
out in the Annex to this Regulation.

Article 2

This Regulation shall enter into force on the 20th day following
that of its publication in the Official Journal of the European
Communities.

This Regulation shall be binding in its entirety and directly applicable in all Member States.

Done at Brussels, 15 July 2002.

For the Commission

David BYRNE

Member of the Commission

(1) OJ L 268, 14.9.1992, p. 54.
(2) OJ L 102, 12.4.2001, p. 63.

L 187/4

EN

Official Journal of the European Communities

16.7.2002

1) Annex A to Directive 92/65/EEC is replaced by the following:

ANNEX

‘ANNEX A

NOTIFIABLE DISEASES IN THE CONTEXT OF THIS DIRECTIVE

Disease

Order/family/species primarily concerned

Newcastle disease, avian influenza

Aves

Psitacosis

American foulbrood

Brucella abortus

Brucella melitensis

Brucella ovis

Brucella suis

Mycobacterium bovis

Psittaciformes

Apis

Antilocapridae, Bovidae, Camelidae, Cervidae, Giraffidae,
Hippopotamidae and Tragulidae

Antilocapridae, Bovidae, Camelidae, Cervidae, Giraffidae,
Hippopotamidae and Tragulidae

Camelidae, Tragulidae, Cervidae, Giraffidae, Bovidae and
Antilocapridae

Cervidae, Leporidae, Ovibos moschatus, Suidae and Tayas-
suidae

Mammalia, in particular Antilocapridae, Bovidae, Came-
lidae, Cervidae, Giraffidae, and Tragulidae

Foot and mouth disease

Artiodactyla and Asian elephants

Classical swine fever, African swine fever

Suidae and Tayassuidae

Swine vesicular disease

Suidae and Tayassuidae

Rinderpest

Bluetongue

Artiodactyla

Antilocapridae, Bovidae, Cervidae, Giraffidae, and Rhino-
cerotidae

Contagious bovine pleuropneumonia

Bovines (including zebu, buffalo, bison and yak)

Vesicular stomatitis

Artiodactyla and Equidae

Peste des petits ruminants

Bovidae and Suidae

Lumpy skin disease

Sheep and goat pox

African horse sickness

Rift valley fever

Bovidae and Giraffidae

Bovidae

Equidae

Bovidae, Camelus species and Rhinocerotidae

Porcine enterovirus encephalomyelitis

Infectious haematopoeitic necrosis

Suidae

Salmonidae

TSE

Anthrax

Rabies

Bovidae, Cervidae, Felidae and Mustelidae

Bovidae, Camelidae, Cervidae, Elephantidae, Equidae and
Hippopotamidae

Carnivora, and Chiroptera’

16.7.2002

EN

Official Journal of the European Communities

L 187/5

2) Annex C to Directive 92/65/EEC is replaced by the following:

‘ANNEX C

CONDITIONS GOVERNING APPROVAL OF BODIES, INSTITUTES OR CENTRES

1. In order to be granted official approval under Article 13(2) of this Directive, a body, institute or centre as defined in

Article 2(1)(c) must:

(a) be clearly demarcated and separated from its surroundings or the animals confined and located so as not to

pose a health risk to agricultural holdings whose health status might be jeopardised;

(b) have adequate means for catching, confining and isolating animals and, have available adequate quarantine

facilities and approved procedures for animals coming from non-approved sources;

(c) be free of the diseases listed in Annex A and the diseases listed in Annex B where the country concerned has a
programme pursuant to Article 14. In order that a body, institute or centre is declared free from these diseases,
the competent authority shall assess the records on the animal health status kept for at least the previous three
years and the results of the clinical and laboratory tests carried out on the animals in the body, institute or
centre. However, by way of derogation from this requirement new establishments shall be approved if the
animals forming the collection are derived from approved establishments;

(d) keep up to date records indicating:

(i) the number and identity (age, sex, species and individual identification where practical) of the animals of

each species present in the establishment;

(ii) the number and identity (age, sex, species and individual identification where practical) of animals arriving
in the establishment or leaving it, together with information on their origin or destination, the transport
from or to the establishment and the animals health status;

(iii) the results of blood tests or any other diagnostic procedures;

(iv) cases of disease and, where appropriate, the treatment administered;

(v) the results of the post-mortem examinations on animals that have died in the establishment, including

still-born animals;

(vi) observations made during any isolation or quarantine period;

(e) either have an arrangement with a competent laboratory to perform post-mortem examinations, or have one or
more appropriate premises where these examinations may be performed by a competent person under the
authority of the approved veterinarian;

(f) either have suitable arrangements or on-site facilities for the appropriate disposal of the bodies of animals

which die of a disease or are euthanised;

(g) secure, by contract or legal instrument, the services of a veterinarian approved by and under the control of the

competent authority, who:

(i) shall comply mutatis mutandis with the requirements referred to in Article 14(3)(B) of Directive 64/

432/EEC,

(ii) shall ensure that appropriate disease surveillance and control measures in relation to the disease situation
of the country concerned are approved by the competent authority and applied in the body, institute or
centre. Such measures shall

include:

— an annual disease surveillance plan including appropriate zoonoses control of the animals,

— clinical,
diseases,

laboratory and post-mortem testing of animals suspected to be affected by transmissible

— vaccination of susceptible animals against infectious diseases as appropriate, only in conformity with

Community legislation;

(iii) shall ensure that any suspect deaths or the presence of any other symptom suggesting that animals have
contracted one or more of the diseases referred to in Annexes A and B is notified without delay to the
competent authority,

if that particular disease is notifiable in the Member State concerned;

(iv) shall ensure that incoming animals have been isolated as necessary, and in accordance with the require-

ments of this Directive and the instructions,

if any, given by the competent authority;

(v) shall be responsible for the day to day compliance with the animal health requirements of this Directive
and of Community legislation on welfare of animals during transport and disposal of animal waste;

(h) if it keeps animals intended for laboratories carrying out experiments, in conformity with the provisions of

Article 5 of Directive 86/609/EEC.

L 187/6

EN

Official Journal of the European Communities

16.7.2002

2. Approval shall be maintained where the following requirements are met:

(a) the premises are under the control of an official veterinarian from the competent authority, who:

(i) shall visit the premises of the body,
(ii) shall audit the activity of the approved veterinarian and the implementation of the annual disease

institute or centre at least once per year;

surveillance plan;

(iii) shall ensure that the provisions of this Directive are met;

(b) only animals coming from another approved body, institute or centre, are introduced into the establishment, in

accordance with the provisions of this Directive;

(c) the official veterinarian verifies that:

— the provisions of this Directive are fulfilled,
— the results of the clinical, post-mortem and laboratory tests on the animals have revealed no occurrence of

the diseases referred to in Annexes A and B;

(d) the body, institute or centre keeps the records referred to in point 1(d) after approval, for a period of at least

ten years.

3. By way of derogation from Article 5(1) of this Directive and point 2(b) of this Annex, animals including apes
(simiae and prosimiae) having an origin other than an approved body, institute or centre may be introduced in an
approved body, institute or centre, provided that these animals undergo a quarantine under official control and in
accordance with the instructions given by the competent authority before being added to the collection.

For apes (simiae and prosimiae) the quarantine requirements laid down in the OIE International Health Code (Chapter
2.10.1 and Appendix 3.5.1) shall be respected.

For other animals undergoing quarantine in accordance with point 2(b) of this Annex, the quarantine period must
be at least 30 days with respect to the diseases listed in Annex A.

4. Animals held in an approved body, institute or centre, shall only leave this establishment if destined to another
approved body, institute or centre, in that Member State or another Member State; however, if not destined to an
approved body, institute or centre, shall only leave in accordance with the requirements of the competent authority
to ensure no risk of possible spread of disease.

5. Where a Member State benefits from additional guarantees under Community legislation it may request appropriate
additional requirements and certification for the susceptible species to be added to the approved body, institute or
centre.

6. The procedures for partly or completely suspending, withdrawing or restoring approval are the following:

(a) where the competent authority finds that the requirements of point 2 have not been fulfilled or there has been
a change of usage which is no longer covered by Article 2 of this Directive the approval shall be suspended or
withdrawn;

(b) where notification is given of the suspicion of one of the diseases listed in Annex A or B, the competent
authority shall suspend approval of the body, institute or centre, until the suspicion has been officially ruled
out. Depending on the disease involved and the risk of disease transmission, the suspension may relate to the
establishment as a whole or only to certain categories of animals susceptible to the disease in question. The
competent authority shall ensure that the measures necessary to confirm or rule out the suspicion and to avoid
any spread of disease are taken, in accordance with Community legislation governing measures to be taken
against the disease in question and on trade in animals;

(c) where the suspected disease is confirmed, the body, institute or centre shall again be approved only when, after
eradication of the disease and source of infection in the premises, including suitable cleaning and disinfection,
the conditions laid down in point 1 of this Annex, with the exception of point 1(c), are again fulfilled;

(d) the competent authority shall inform the Commission of the suspension, withdrawal or restoration of approval

of a body,

institute or centre.’

3) Annex E to Directive 92/65/EEC is replaced by the following:

16.7.2002

EN

Official Journal of the European Communities

L 187/7

‘ANNEX E

Part 1

L 187/8

EN

Official Journal of the European Communities

16.7.2002

16.7.2002

EN

Official Journal of the European Communities

L 187/9

Part 2

L 187/10

EN

Official Journal of the European Communities

16.7.2002

16.7.2002

EN

Official Journal of the European Communities

L 187/11

Part 3

L 187/12

EN

Official Journal of the European Communities

16.7.2002